<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="Publisher" Owner="NLM"><PMID Version="1">38700658</PMID><DateRevised><Year>2024</Year><Month>05</Month><Day>03</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1439-0973</ISSN><JournalIssue CitedMedium="Internet"><PubDate><Year>2024</Year><Month>May</Month><Day>03</Day></PubDate></JournalIssue><Title>Infection</Title><ISOAbbreviation>Infection</ISOAbbreviation></Journal><ArticleTitle>Long-term symptoms after SARS-CoV-2 infection in a cohort of people living with HIV.</ArticleTitle><ELocationID EIdType="doi" ValidYN="Y">10.1007/s15010-024-02288-9</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Our Hospital in Northern Italy assists 3817 people living with HIV (PLWH) and has faced the impact of COVID-19. Little is known about the impact of HIV infection on the risk of post-COVID-19 conditions (PCCs) onset. We aim to assess the incidence of PCC in PLWH and the factors associated with its occurrence.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">We performed a retrospective, observational study including all PLWH&#x2009;&gt;&#x2009;18&#xa0;years registered in the Brescia Health Protection Agency database, assessing SARS-CoV-2 burden, vaccination status, socio-demographic, and viro-immunological parameters from February 2020 until May 2022. Persistence of self-reported symptoms (clustered into gastrointestinal, respiratory, osteo-muscular, and neuro-behavioral symptoms) was evaluated after 3&#xa0;months by a telephone-administered questionnaire. We estimated the associations between all variables and outcomes through univariate and multivariable logistic models.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">In the study period, 653 PLWH were diagnosed with SARS-CoV-2 infection (17.1%). We observed 19 (2.9%) reinfections, 71 (10.9%) hospitalizations, and 3 (0.5%) deaths. We interviewed 510/653 PLWH (78%), and 178 (PCCs prevalence 34.9%; CI 95% 30.7-39.2) reported persistent symptoms. Asthenia/fatigue was the most reported symptom (60/178), followed by muscular pain (54/178). In the multivariate regression model, there was a lower risk of PCCs in males respect to females (adjusted OR&#x2009;=&#x2009;0.64; CI 95% 0.99-3.66), while hospitalization during acute infection was associated with an increased the risk of PCCs (adjusted OR&#x2009;=&#x2009;1.9; CI 95% 0.99-3.66). Notably, no viro-immunological variable modified the PCCs risk onset.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Our study highlights a substantial prevalence of PCCs among PLWH, three months post-SARS-CoV-2 infection, independent of viro-immunological features or vaccination status.</AbstractText><CopyrightInformation>&#xa9; 2024. The Author(s).</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y" EqualContrib="Y"><LastName>Degli Antoni</LastName><ForeName>Melania</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Unit of Infectious and Tropical Diseases, Department of Clinical and Experimental Sciences, ASST Spedali Civili Di Brescia and University of Brescia, Brescia, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Maifredi</LastName><ForeName>Giovanni</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>ATS Brescia (Brescia Health Protection Agency), Brescia, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Storti</LastName><ForeName>Samuele</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Unit of Infectious and Tropical Diseases, Department of Clinical and Experimental Sciences, ASST Spedali Civili Di Brescia and University of Brescia, Brescia, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tiecco</LastName><ForeName>Giorgio</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Unit of Infectious and Tropical Diseases, Department of Clinical and Experimental Sciences, ASST Spedali Civili Di Brescia and University of Brescia, Brescia, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Di Gregorio</LastName><ForeName>Marco</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Unit of Infectious and Tropical Diseases, Department of Clinical and Experimental Sciences, ASST Spedali Civili Di Brescia and University of Brescia, Brescia, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rossi</LastName><ForeName>Benedetta</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Unit of Infectious and Tropical Diseases, Department of Clinical and Experimental Sciences, ASST Spedali Civili Di Brescia and University of Brescia, Brescia, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gasparotti</LastName><ForeName>Cinzia</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>ATS Brescia (Brescia Health Protection Agency), Brescia, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Foc&#xe0;</LastName><ForeName>Emanuele</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Unit of Infectious and Tropical Diseases, Department of Clinical and Experimental Sciences, ASST Spedali Civili Di Brescia and University of Brescia, Brescia, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Castelli</LastName><ForeName>Francesco</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Unit of Infectious and Tropical Diseases, Department of Clinical and Experimental Sciences, ASST Spedali Civili Di Brescia and University of Brescia, Brescia, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Quiros-Roldan</LastName><ForeName>Eugenia</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Unit of Infectious and Tropical Diseases, Department of Clinical and Experimental Sciences, ASST Spedali Civili Di Brescia and University of Brescia, Brescia, Italy. eugeniaquiros@yahoo.it.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>05</Month><Day>03</Day></ArticleDate></Article><MedlineJournalInfo><Country>Germany</Country><MedlineTA>Infection</MedlineTA><NlmUniqueID>0365307</NlmUniqueID><ISSNLinking>0300-8126</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">COVID-19</Keyword><Keyword MajorTopicYN="N">HIV</Keyword><Keyword MajorTopicYN="N">Long-COVID</Keyword><Keyword MajorTopicYN="N">PLWH</Keyword><Keyword MajorTopicYN="N">Post-COVID-19 conditions</Keyword><Keyword MajorTopicYN="N">Post-acute sequelae of SARS-CoV-2</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>2</Month><Day>14</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>4</Month><Day>26</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>5</Month><Day>3</Day><Hour>12</Hour><Minute>51</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>5</Month><Day>3</Day><Hour>12</Hour><Minute>51</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>5</Month><Day>3</Day><Hour>11</Hour><Minute>8</Minute></PubMedPubDate></History><PublicationStatus>aheadofprint</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">38700658</ArticleId><ArticleId IdType="doi">10.1007/s15010-024-02288-9</ArticleId><ArticleId IdType="pii">10.1007/s15010-024-02288-9</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Larsen NW, Stiles LE, Miglis MG. Preparing for the long-haul: autonomic complications of COVID-19. Auton Neurosci. 2021;235:102841.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.autneu.2021.102841</ArticleId><ArticleId IdType="pubmed">34265539</ArticleId><ArticleId IdType="pmc">8254396</ArticleId></ArticleIdList></Reference><Reference><Citation>World Health Organization. A clinical case definition of post COVID-19 condition by a Delphi consensus [Internet]. 2021 Oct. Report No.: WHO/2019-nCoV/Post_COVID-19_condition/Clinical_case_definition/2021.1. https://www.who.int/publications/i/item/WHO-2019-nCoV-Post_COVID-19_condition-Clinical_case_definition-2021.1</Citation></Reference><Reference><Citation>Chen C, Haupert SR, Zimmermann L, Shi X, Fritsche LG, Mukherjee B. Global prevalence of post-coronavirus disease 2019 (COVID-19) condition or long COVID: a meta-analysis and systematic review. J Infect Dis. 2022;226:1593&#x2013;607.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/infdis/jiac136</ArticleId><ArticleId IdType="pubmed">35429399</ArticleId></ArticleIdList></Reference><Reference><Citation>Castanares-Zapatero D, Chalon P, Kohn L, Dauvrin M, Detollenaere J, Maertens De Noordhout C, et al. Pathophysiology and mechanism of long COVID: a comprehensive review. Ann Med. 2022;54:1473&#x2013;87.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/07853890.2022.2076901</ArticleId><ArticleId IdType="pubmed">35594336</ArticleId><ArticleId IdType="pmc">9132392</ArticleId></ArticleIdList></Reference><Reference><Citation>Moyo E, Chimene M, Moyo P, Musuka G, Mangoya D, Murewanhema G, et al. Risk factors and clinical presentations of long COVID in Africa: a scoping review. J Infect Public Health. 2023;16:1982&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jiph.2023.09.021</ArticleId><ArticleId IdType="pubmed">37890221</ArticleId></ArticleIdList></Reference><Reference><Citation>Tsampasian V, Elghazaly H, Chattopadhyay R, Debski M, Naing TKP, Garg P, et al. Risk factors associated with post&#x2212;COVID-19 condition: a systematic review and meta-analysis. JAMA Intern Med. 2023;183:566.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamainternmed.2023.0750</ArticleId><ArticleId IdType="pubmed">36951832</ArticleId><ArticleId IdType="pmc">10037203</ArticleId></ArticleIdList></Reference><Reference><Citation>Turtle L, Thorpe M, Drake TM, Swets M, Palmieri C, Russell CD, et al. Outcome of COVID-19 in hospitalised immunocompromised patients: an analysis of the WHO ISARIC CCP-UK prospective cohort study. PLOS Med. 2023;20:e1004086.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pmed.1004086</ArticleId><ArticleId IdType="pubmed">36719907</ArticleId><ArticleId IdType="pmc">9928075</ArticleId></ArticleIdList></Reference><Reference><Citation>Kamanzi P, Mulundu G, Mutale K, Mumba C, Ngalamika O. HIV and inflammatory markers are associated with persistent COVID-19 symptoms. Immun Inflamm Dis. 2023;11:e859.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/iid3.859</ArticleId><ArticleId IdType="pubmed">37249281</ArticleId><ArticleId IdType="pmc">10165949</ArticleId></ArticleIdList></Reference><Reference><Citation>Istituto Superiode di Sanit&#xe0; (ISS), EpiCentro. EpiCentro, L&#x2019;epidemiologia per la sanit&#xe0; pubblica. Monitoraggio delle varianti del virus SARS-CoV-2 di interesse in sanit&#xe0; pubblica in Italia - Archivio dei rapporti periodici. https://www.epicentro.iss.it/coronavirus/sars-cov-2-monitoraggio-varianti-rapporti-periodici</Citation></Reference><Reference><Citation>Istituto Superiore di Sanit&#xe0; (ISS), EpiCentro. Prevalenza e distribuzione delle varianti di SARS-CoV-2 di interesse per la sanit&#xe0; pubblica in Italia [Internet]. 2022 Jan. Report No.: 16. https://www.epicentro.iss.it/coronavirus/pdf/sars-cov-2-monitoraggio-varianti-rapporti-periodici-19-gennaio-2022.pdf</Citation></Reference><Reference><Citation>Mannucci PM, Galbussera AA, D&#x2019;Avanzo B, Tettamanti M, Remuzzi G, Fortino I, et al. Two years of SARS-CoV-2 pandemic and COVID-19 in Lombardy. Italy Intern Emerg Med. 2023;18:1445&#x2013;51.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11739-023-03315-7</ArticleId><ArticleId IdType="pubmed">37314640</ArticleId></ArticleIdList></Reference><Reference><Citation>Tiecco G, Storti S, Degli Antoni M, Foc&#xe0; E, Castelli F, Quiros-Roldan E. Omicron genetic and clinical peculiarities that may overturn SARS-CoV-2 pandemic: a literature review. Int J Mol Sci. 2022;23:1987.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms23041987</ArticleId><ArticleId IdType="pubmed">35216104</ArticleId><ArticleId IdType="pmc">8876558</ArticleId></ArticleIdList></Reference><Reference><Citation>Ministero della Salute, Istituto Superiore di Sanit&#xe0;. Report 89 Sintesi nazionale Monitoraggio Fase 2 (DM Salute 30 aprile 2020) [Internet]. 2021 Jan. Report No.: 89. https://www.salute.gov.it/portale/nuovocoronavirus/dettaglioMonitoraggioNuovoCoronavirus.jsp?lingua=italiano&amp;menu=monitoraggi&amp;id=99</Citation></Reference><Reference><Citation>Centers for Disease Control and Prevention. cdc.gov. COVID-19 Vaccines for Specific Groups of People. https://www.cdc.gov/coronavirus/2019-ncov/vaccines/recommendations/specific-groups.html</Citation></Reference><Reference><Citation>Maifredi G, Izzo I, Gasparotti C, Sileo CV, Castelli F, HIV-CoV Group, et al. SARS-CoV-2 Infection and Vaccination Coverage among Fragile Populations in a Local Health Area of Northern Italy. Life. 2022;12:1009.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/life12071009</ArticleId><ArticleId IdType="pubmed">35888096</ArticleId><ArticleId IdType="pmc">9316873</ArticleId></ArticleIdList></Reference><Reference><Citation>Quiros-Roldan E, Magro P, Carriero C, Chiesa A, El Hamad I, Tratta E, et al. Consequences of the COVID-19 pandemic on the continuum of care in a cohort of people living with HIV followed in a single center of Northern Italy. AIDS Res Ther. 2020;17:59.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12981-020-00314-y</ArticleId><ArticleId IdType="pubmed">33012282</ArticleId><ArticleId IdType="pmc">7533114</ArticleId></ArticleIdList></Reference><Reference><Citation>H&#xf6;ft MA, Burgers WA, Riou C. The immune response to SARS-CoV-2 in people with HIV. Cell Mol Immunol. 2023;21:184&#x2013;96.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41423-023-01087-w</ArticleId><ArticleId IdType="pubmed">37821620</ArticleId><ArticleId IdType="pmc">10806256</ArticleId></ArticleIdList></Reference><Reference><Citation>Nguyen VT, Nagavedu K, Morrison M, Chen T, Randall LM, Landazabal C, et al. COVID-19 severity in people with HIV compared to those without HIV. J Acquir Immune Defic Syndr. 1999. https://doi.org/10.1097/QAI.0000000000003378 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/QAI.0000000000003378</ArticleId><ArticleId IdType="pubmed">10534150</ArticleId></ArticleIdList></Reference><Reference><Citation>Groff D, Sun A, Ssentongo AE, Ba DM, Parsons N, Poudel GR, et al. Short-term and long-term rates of postacute sequelae of SARS-CoV-2 infection: a systematic review. JAMA Netw Open. 2021;4:e2128568.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamanetworkopen.2021.28568</ArticleId><ArticleId IdType="pubmed">34643720</ArticleId><ArticleId IdType="pmc">8515212</ArticleId></ArticleIdList></Reference><Reference><Citation>Kahlert CR, Strahm C, G&#xfc;sewell S, Cusini A, Brucher A, Goppel S, et al. Post-acute sequelae after severe acute respiratory syndrome coronavirus 2 infection by viral variant and vaccination status: a multicenter cross-sectional study. Clin Infect Dis. 2023;77:194&#x2013;202.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/cid/ciad143</ArticleId><ArticleId IdType="pubmed">36905145</ArticleId><ArticleId IdType="pmc">10371307</ArticleId></ArticleIdList></Reference><Reference><Citation>Azzolini E, Levi R, Sarti R, Pozzi C, Mollura M, Mantovani A, et al. Association between BNT162b2 vaccination and long COVID after infections not requiring hospitalization in health care workers. JAMA. 2022;328:676.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2022.11691</ArticleId><ArticleId IdType="pubmed">35796131</ArticleId><ArticleId IdType="pmc">9250078</ArticleId></ArticleIdList></Reference><Reference><Citation>Ballouz T, Menges D, Kaufmann M, Amati R, Frei A, Von Wyl V, et al. Post COVID-19 condition after wildtype, delta, and omicron SARS-CoV-2 infection and prior vaccination: pooled analysis of two population-based cohorts. PLOS&#xa0;One. 2023;18:e0281429.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0281429</ArticleId><ArticleId IdType="pubmed">36812215</ArticleId><ArticleId IdType="pmc">9946205</ArticleId></ArticleIdList></Reference><Reference><Citation>Marra AR, Kobayashi T, Callado GY, Pardo I, Gutfreund MC, Hsieh MK, et al. The effectiveness of COVID-19 vaccine in the prevention of post-COVID conditions: a systematic literature review and meta-analysis of the latest research. Antimicrob Steward Healthc Epidemiol. 2023;3:e168.</Citation><ArticleIdList><ArticleId IdType="doi">10.1017/ash.2023.447</ArticleId><ArticleId IdType="pubmed">38028898</ArticleId><ArticleId IdType="pmc">10644173</ArticleId></ArticleIdList></Reference><Reference><Citation>Hastie CE, Lowe DJ, McAuley A, Mills NL, Winter AJ, Black C, et al. True prevalence of long-COVID in a nationwide, population cohort study. Nat Commun. 2023;14:7892.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-023-43661-w</ArticleId><ArticleId IdType="pubmed">38036541</ArticleId><ArticleId IdType="pmc">10689486</ArticleId></ArticleIdList></Reference><Reference><Citation>Peluso MJ, Spinelli MA, Deveau TM, Forman CA, Munter SE, Mathur S, et al. Postacute sequelae and adaptive immune responses in people with HIV recovering from SARS-COV-2 infection. AIDS. 2022;36:F7-16.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/QAD.0000000000003338</ArticleId><ArticleId IdType="pubmed">35866847</ArticleId></ArticleIdList></Reference><Reference><Citation>Almomen A, Cox J, Lebouch&#xe9; B, Cheng MP, Frenette C, Routy JP, et al. Short communication: ongoing impact of the social determinants of health during the second and third waves of the COVID-19 pandemic in people living with hiv receiving care in a montreal-based tertiary care center. AIDS Res Hum Retroviruses. 2022;38:359&#x2013;62.</Citation><ArticleIdList><ArticleId IdType="doi">10.1089/aid.2021.0186</ArticleId><ArticleId IdType="pubmed">35172609</ArticleId></ArticleIdList></Reference><Reference><Citation>Jassat W, Mudara C, Vika C, Welch R, Arendse T, Dryden M, et al. A cohort study of post-COVID-19 condition across the beta, delta, and omicron waves in South Africa: 6-month follow-up of hospitalized and nonhospitalized participants. Int J Infect Dis. 2023;128:102&#x2013;11.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijid.2022.12.036</ArticleId><ArticleId IdType="pubmed">36587841</ArticleId><ArticleId IdType="pmc">9800016</ArticleId></ArticleIdList></Reference><Reference><Citation>Karuna S, Gallardo-Cartagena JA, Theodore D, Hunidzarira P, Montenegro-Idrogo J, Hu J, et al. Post-COVID symptom profiles and duration in a global convalescent COVID-19 observational cohort: Correlations with demographics, medical history, acute COVID-19 severity and global region. J Glob Health. 2023;23:06020.</Citation><ArticleIdList><ArticleId IdType="doi">10.7189/jogh.13.06020</ArticleId></ArticleIdList></Reference><Reference><Citation>Mazzitelli M, Trunfio M, Sasset L, Leoni D, Castelli E, Lo Menzo S, et al. Factors associated with severe COVID-19 and post-acute COVID-19 syndrome in a cohort of people living with HIV on antiretroviral treatment and with undetectable HIV RNA. Viruses. 2022;14:493.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/v14030493</ArticleId><ArticleId IdType="pubmed">35336900</ArticleId><ArticleId IdType="pmc">8954437</ArticleId></ArticleIdList></Reference><Reference><Citation>Peluso MJ, Deveau TM, Munter SE, Ryder D, Buck A, Beck-Engeser G, et al. Chronic viral coinfections differentially affect the likelihood of developing long COVID. J Clin Invest. 2023;133:e163669.</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/JCI163669</ArticleId><ArticleId IdType="pubmed">36454631</ArticleId><ArticleId IdType="pmc">9888380</ArticleId></ArticleIdList></Reference><Reference><Citation>Pujari S, Gaikwad S, Chitalikar A, Dabhade D, Joshi K, Bele V. Long-coronavirus disease among people living with HIV in western India: an observational study. Immun Inflamm Dis. 2021;9:1037&#x2013;43.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/iid3.467</ArticleId><ArticleId IdType="pubmed">34078004</ArticleId><ArticleId IdType="pmc">8239760</ArticleId></ArticleIdList></Reference><Reference><Citation>Yue Y, Liang C, Weissman S, Lyu T, Olatosi B, Li X. 12-MONTH CONSEQUENCES IN PEOPLE WITH HIV/SARS-CoV-2 COINFECTION: NATIONAL EHR COHORT. CROI 2023 Abstr Ebook [Internet]. 884. https://www.croiconference.org/croi-2023-resources/</Citation></Reference><Reference><Citation>Durstenfeld MS, Peluso MJ, Spinelli MA, Li D, Sander E, Swaminathan S, Arechiga V, Hoh R,, Aras MA, Long CS, Deeks SG, Hsue P. EXERCISE CAPACITY IS REDUCED IN HIV INDEPENDENT OF SARS-CoV-2 INFECTION. CROI 2023 Abstr Ebook [Internet]. 2023;666. https://www.croiconference.org/croi-2023-resources/</Citation></Reference><Reference><Citation>Yendewa GA, Perez JA, Patil N, McComsey GA. HIV INFECTION INCREASES RISK OF PASC WHILE COVID-19 VACCINATION IS PROTECTIVE. CROI 2023 Abstr Ebook. 724.</Citation></Reference><Reference><Citation>Antar A, Gallego Marquez N, Jamal A, Alisha Dziarski A, Fu J, Walch S, Romero A, Queiroz A, Araujo-Pereira M, Zelaya A, Akasreku E, Andrade B, Peluso M, Landay A. SYMPTOMS AND BIOMARKERS OF LONG COVID IN PEOPLE LIVING WITH AND WITHOUT HIV. CROI 2023 Abstract ebook [Internet]. 2023; https://www.croiconference.org/croi-2023-resources/</Citation></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>